Influence of gender and timing of initiation of treatment on LiCl enhancement of NZB/W survival

Journal of Trace and Microprobe Techniques

Volumn 15, Issue 1, 1997, Pages 101-107

  Hart, David A ^a   Lenz, Steven P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Influence of gender; Li and NZB W mice; Li and renal disease; Murine SLE model

Indexed keywords

EID: 26444464383     PISSN: 07334680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Beyer MM, Steinberg AD, Nicastri AD, Friedman EA (1977) Unilateral nephrectomy: effect on survival in NZB/NZW mice. Science 198, 511-513.
2. Birch NJ (1988) Lithium: Inorganic Pharmacology and Psychiatric Use. IRL Press, Oxford.
3. Done S, Lenz SP, Benediktsson H, Fritzler MJ, Martin L, Krause G, Zhao P, Hart DA (1994) The effect of lithium on murine models of lupus nephritis. Lab. Invest. 7, 156A.
4. Hart DA (1991) Lithium, lymphocytes, and the neuroimmune interface. In: Lithium and the Blood, V Gallicchio ed., Karger, Basel, pp.68-78.
5. Hart DA (1991) Immunoregulation in patients receiving lithium for affective disorders. In: Lithium and the Blood, V Gallicchio ed., Karger, Basel, pp.46-67.
6. Hart DA (1991) Lithium, lymphocytes and labyrinths: insights into biological regulation and diversity. In: Lithium and the Cell: Inorganic Pharmacology and Biochemistry, NJ Birch ed., Academic Press, London, pp.289-315.
7. Hart DA, Done SJ, Benediktsson H, Lenz SP (1994) Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride. Int. J. Immunopharmac. 16, 825-833.
8. Hart DA, Lenz SP (1993) ) Lithium chloride treatment of BxSB male mice decreases survival in this murine model of SLE: possible role for gender-dependent variables. Lithium 4, 139-141.
9. Hart DA, Lenz SP (1993) Lithium chloride in the drinking water does not enhance survival of NZB/W lupus mice. Lithium 4, 271-277.
10. Hart DA, Zhao P, Lenz SP, Martin L, Fritzler MJ, Done S, Benediktsson H, Krause G (1993) Lithium treatment of MRL-lpr mice alters disease progression in this murine model of systemic lupus erythematosus. Lithium 4, 61-68.
11. Johnson FN (1984) The History of Lithium Therapy. MacMillan Press, London.
12. Krause G, Zhao P, Martin L, Fritzler MJ, Benediktsson H, Hart DA (1992) LiCl prolongs survival and alters disease progression in the NZB/W model of SLE. Lithium 3, 61-67.
13. Lenz SP, Pak C, Hart DA (1994) Low dose LiCl enhances survival and inhibits pancreatic beta cell destruction in the NOD model of type 1 diabetes. Lithium 5, 139-146.
14. Lenz SP, Izui S, Benediktsson H, Hart DA (1995) LiCl enhances survival of NZB/W mice: influence of melatonin and timing of treatment. Int. J. Immunopharmacol. 17, 581-592.
15. Lenz SP, Hart DA (1997) LiCl treatment of female NZB/W mice leads to alterations in gene expression in renal tissue. J Trace Microprobe Techniques (in press).
16. Lydiard R, Gelenberg A (1982) Hazards and adverse effects of lithium. Ann. Rev. Med. 33, 327-344.
17. McMurray R, Keisler D, Izui S, Walker SE (1994) Hyperprolactinemia in male NZB/NZW(B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin. Immunol. Immunopathol. 71, 338-343.
18. Niu EM, Mesequer A, Catterall JF (1991) Genomic organization and DNA sequence of the mouse kidney androgen-regulated protein (KAP) gene. DNA Cell Biol. 10, 41-48.
19. Smith AR (1977) The laboratory mouse. Lab. Animals 6, 66-73.
20. Zhao P, Krause G, Hart DA (1991) Influence of Li-7 on disease progression in murine models of diabetes: differences between NOD and obese mice. Lithium 2, 227-234.